Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'clomipramine' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 884 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Rosenwasser, AM
      Alcohol, antidepressants, and circadian rhythms - Human and animal models

      ALCOHOL RESEARCH & HEALTH
    2. Steiner, M; Romano, SJ; Babcock, S; Dillon, J; Shuler, C; Berger, C; Carter, D; Reid, R; Stewart, D; Steinberg, S; Judge, R
      The efficacy of fluoxetine in improving physical symptoms associated with premenstrual dysphoric disorder

      BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY
    3. Rowland, DL; Brazao, CAD; Slob, AK
      Effective daily treatment with clomipramine in men with premature ejaculation when 25 mg (as required) is ineffective

      BJU INTERNATIONAL
    4. Fritze, J; Moller, HJ
      Design of clinical trials of antidepressants - Should a placebo control arm be included?

      CNS DRUGS
    5. Himle, JA; Rassi, S; Haghighatgou, H; Krone, KP; Nesse, RM; Abelson, J
      Group behavioral therapy of Obsessive-Compulsive Disorder: Seven vs. twelve-week outcomes

      DEPRESSION AND ANXIETY
    6. Overall, KL
      Pharmacological treatment in behavioural medicine: The importance of neurochemistry, molecular biology and mechanistic hypotheses

      VETERINARY JOURNAL
    7. Schroeder, SR; Oster-Granite, ML; Berkson, G; Bodfish, JW; Breese, GR; Cataldo, MF; Cook, EH; Crnic, LS; DeLeon, I; Fisher, W; Harris, JC; Horner, RH; Iwata, B; Jinnah, HA; King, BH; Lauder, JM; Lewis, MH; Newell, K; Nyhan, WL; Rojahn, J; Sackett, GP; Sandman, C; Symons, F; Tessel, RE; Thompson, T; Wong, DF
      Self-injurious behavior: Gene-brain-behavior relationships

      MENTAL RETARDATION AND DEVELOPMENTAL DISABILITIES RESEARCH REVIEWS
    8. Zerjav-Lacombe, S; Dewan, V
      Possible serotonin syndrome associated with clomipramine after withdrawal of clozapine

      ANNALS OF PHARMACOTHERAPY
    9. Hand, I; Peter, H; Rufer, M
      Combined behavioral and pharmacological treatment for obsessive-compulsivedisorders: Research findings and clinical practice

      VERHALTENSTHERAPIE
    10. Abdel-Hamid, IA; El Naggar, EA; El Gilany, AH
      Assessment of as needed use of pharmacotherapy and the pause-squeeze technique in premature ejaculation

      INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH
    11. Drago, F; Nicolosi, A; Micale, V; Lo Menzo, G
      Placebo affects the performance of rats in models of depression: is it a good control for behavioral experiments?

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    12. Turcotte, JE; Debonnel, G; de Montigny, C; Hebert, C; Blier, P
      Assessment of the serotonin and norepinephrine reuptake blocking properties of duloxetine in healthy subjects

      NEUROPSYCHOPHARMACOLOGY
    13. Thomsen, PH; Ebbesen, C; Persson, C
      Long-term experience with citalopram in the treatment of adolescent OCD

      JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
    14. Geller, DA; Hoog, SL; Heiligenstein, JH; Ricardi, RK; Tamura, R; Kluszynski, S; Jacobson, JG
      Fluoxetine treatment for obsessive-compulsive disorder in children and adolescents: A placebo-controlled clinical trial

      JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
    15. Riddle, MA; Reeve, EA; Yaryura-Tobias, JA; Yang, HM; Claghorn, JL; Gaffney, G; Greist, JH; Holland, D; McConville, BJ; Pigott, T; Walkup, JT
      Fluvoxamine for children and adolescents with obsessive-compulsive disorder: A randomized, controlled, multicenter trial

      JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
    16. Thienemann, M; Martin, J; Cregger, B; Thompson, HB; Dyer-Friedman, J
      Manual-driven group cognitive-behavioral therapy for adolescents with obsessive-compulsive disorder: A pilot study

      JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
    17. Cook, EH; Wagner, KD; March, JS; Biederman, J; Landau, P; Wolkow, R; Messig, M
      Long-term sertraline treatment of children and adolescents with obsessive-compulsive disorder

      JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
    18. Mundo, E; Rouillon, F; Figuera, ML; Stigler, M
      Fluvoxamine in obsessive-compulsive disorder: similar efficacy but superior tolerability in comparison with clomipramine

      HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
    19. Rivas-Vazquez, RA
      Antidepressants as first-line agents in the current pharmacotherapy of anxiety disorders

      PROFESSIONAL PSYCHOLOGY-RESEARCH AND PRACTICE
    20. Lam, JN; Steketee, GS
      Reducing obsessions and compulsions through behavior therapy

      PSYCHOANALYTIC INQUIRY
    21. Micallef, J; Blin, O
      Neurobiology and clinical pharmacology of obsessive-compulsive disorder

      CLINICAL NEUROPHARMACOLOGY
    22. Galeotti, N; Ghelardini, C; Zoppi, M; Del Bene, E; Raimondi, L; Beneforti, E; Bartolini, A
      Hypofunctionality of Gi proteins as aetiopathogenic mechanism for migraineand cluster headache

      CEPHALALGIA
    23. Khanna, S; John, JP; Reddy, PL
      Neuroendocrine and behavioral responses to mCPP in obsessive-compulsive disorder

      PSYCHONEUROENDOCRINOLOGY
    24. Seeger, G; Schloss, P; Schmidt, MH
      Marker gene polymorphisms in hyperkinetic disorder - predictors of clinical response to treatment with methylphenidate?

      NEUROSCIENCE LETTERS
    25. Hernandez, A; Laurido, C; Mondaca, M; Pelissier, T; Burgos, H; Soto-Moyano, R
      Lesion of the bulbospinal noradrenergic pathways blocks desipramine-induced inhibition of the C-fiber evoked nociceptive reflex in rats

      NEUROSCIENCE LETTERS
    26. Ruggiero, GM; Laini, V; Mauri, MC; Ferrari, VMS; Clemente, A; Lugo, F; Mantero, M; Redaelli, G; Zappulli, D; Cavagnini, F
      A single blind comparison of amisulpride, fluoxetine and clomipramine in the treatment of restricting anorectics

      PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
    27. Palego, L; Dell'Osso, L; Marazziti, D; Biondi, L; Sarno, N; Ciapparelli, A; Giromella, A; Giannaccini, G; Lucacchini, A; Cassano, GB
      Simultaneous analysis of clozapine, clomipramine and their metabolites by reversed-phase liquid chromatography

      PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
    28. Erzegovesi, S; Cavallini, MC; Cavedini, P; Diaferia, G; Locatelli, M; Bellodi, L
      Clinical predictors of drug response in obsessive-compulsive disorder

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    29. Romano, S; Goodman, W; Tamura, R; Gonzales, J
      Long-term treatment of obsessive-compulsive disorder after an acute response: A comparison of fluoxetine versus placebo

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    30. Melichar, JK; Haida, A; Rhodes, C; Reynolds, AH; Nutt, DJ; Malizia, AL
      Venlafaxine occupation at the noradrenaline reuptake site: in-vivo determination in healthy volunteers

      JOURNAL OF PSYCHOPHARMACOLOGY
    31. Lotufo-Neto, F; Bernik, M; Ramos, RT; Andrade, L; Gorenstein, C; Cordas, T; Melo, M; Gentil, V
      A dose-finding and discontinuation study of clomipramine in panic disorder

      JOURNAL OF PSYCHOPHARMACOLOGY
    32. Stein, DJ; Montgomery, SA; Kasper, S; Tanghoj, P
      Predictors of response to pharmacotherapy with citalopram in obsessive-compulsive disorder

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    33. Montgomery, SA
      A meta-analysis of the efficacy and tolerability of paroxetine versus tricyclic antidepressants in the treatment of major depression

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    34. Montgomery, SA; Kasper, S; Stein, DJ; Hedegaard, KB; Lemming, OM
      Citalopram 20 mg, 40 mg and 60 mg are all effective and well tolerated compared with placebo in obsessive-compulsive disorder

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    35. Maina, G; Albert, U; Bogetto, F
      Relapses after discontinuation of drug associated with increased resistance to treatment in obsessive-complusive disorder

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    36. Labrador, FJ; Crespo, M
      Efficacious psychological treatments for sexual dysfunctions

      PSICOTHEMA
    37. Perna, G; Bertani, A; Caldirola, D; Smeraldi, E; Bellodi, L
      A comparison of citalopram and paroxetine in the treatment of panic disorder: A randomized, single-blind study

      PHARMACOPSYCHIATRY
    38. Alonso, P; Menchon, JM; Pifarre, J; Mataix-Cols, D; Torres, L; Salgado, P; Vallejo, J
      Long-term follow-up and predictors of clinical outcome in obsessive-compulsive patients treated with serotonin reuptake inhibitors and behavioral therapy

      JOURNAL OF CLINICAL PSYCHIATRY
    39. Grant, JE
      Successful treatment of nondelusional body dysmorphic disorder with olanzapine: A case report

      JOURNAL OF CLINICAL PSYCHIATRY
    40. Phillips, KA; McElroy, SL; Dwight, MM; Eisen, JL; Rasmussen, SA
      Delusionality and response to open-label fluvoxamine in body dysmorphic disorder

      JOURNAL OF CLINICAL PSYCHIATRY
    41. Keuthen, NJ; Fraim, C; Deckersbach, T; Dougherty, DD; Baer, L; Jenike, MA
      Longitudinal follow-up of naturalistic treatment outcome in patients with trichotillomania

      JOURNAL OF CLINICAL PSYCHIATRY
    42. Leonard, HL; Freeman, J; Garcia, A; Garvey, M; Snider, L; Swedo, SE
      Obsessive-compulsive disorder and related conditions

      PEDIATRIC ANNALS
    43. Screponi, E; Carosa, E; Di Stasi, SM; Pepe, M; Carruba, G; Jannini, EA
      Prevalence of chronic prostatitis in men with premature ejaculation

      UROLOGY
    44. March, JS; Franklin, M; Nelson, A; Foa, E
      Cognitive-behavioral psychotherapy for pediatric obsessive-compulsive disorder

      JOURNAL OF CLINICAL CHILD PSYCHOLOGY
    45. Grados, MA; Riddle, MA
      Pharmacological treatment of childhood obsessive-compulsive disorder: Fromtheory to practice

      JOURNAL OF CLINICAL CHILD PSYCHOLOGY
    46. Rivarola, HW; Fernandez, AR; Enders, JE; Fretes, R; Gea, S; Paglini-Oliva, P
      Effects of clomipramine on Trypanosoma cruzi infection in mice

      TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
    47. Takamori, K; Yoshida, S; Okuyama, S
      Availability of learned helplessness test as a model of depression compared to a forced swimming test in rats

      PHARMACOLOGY
    48. Pallotta, M; Segieth, J; Sadideen, F; Whitton, PS
      Repeated but not acute clomipramine decreases the effect of N-methyl-D-aspartate receptor activation on serotonergic transmission between the raphe nuclei and frontal cortex

      NEUROPHARMACOLOGY
    49. Galeotti, N; Ghelardini, C; Bartolini, A
      Involvement of potassium channels in amitriptyline and clomipramine analgesia

      NEUROPHARMACOLOGY
    50. Jenike, MA
      An update on obsessive-compulsive disorder

      BULLETIN OF THE MENNINGER CLINIC
    51. Spreux-Varoquaux, O; Alvarez, JC; Berlin, I; Batista, G; Despierre, PG; Gilton, A; Cremniter, D
      Differential abnormalities in plasma 5-HIAA and platelet serotonin concentrations in violent suicide attempters - Relationships with impulsivity and depression

      LIFE SCIENCES
    52. Seo, KK; Kim, SC; Lee, MY
      Comparison of peripheral inhibitory effects of clomipramine with selectiveserotonin re-uptake inhibitors on contraction of vas deferens: In vitro and in vivo studies

      JOURNAL OF UROLOGY
    53. Manganotti, P; Bortolomasi, M; Zanette, G; Pawelzik, T; Giacopuzzi, M; Fiaschi, A
      Intravenous clomipramine decreases excitability of human motor cortex. A study with paired magnetic stimulation

      JOURNAL OF THE NEUROLOGICAL SCIENCES
    54. Keuthen, NJ; Wilhelm, S; Deckersbach, T; Engelhard, IM; Forker, AE; Baer, L; Jenike, MA
      The Skin Picking Scale - Scale construction and psychometric analyses

      JOURNAL OF PSYCHOSOMATIC RESEARCH
    55. Hisaoka, K; Nishida, A; Koda, T; Miyata, M; Zensho, H; Morinobu, S; Ohta, M; Yamawaki, S
      Antidepressant drug treatments induce glial cell line-derived neurotrophicfactor (GDNF) synthesis and release in rat C6 glioblastoma cells

      JOURNAL OF NEUROCHEMISTRY
    56. Pelissier, T; Hernandez, A; Mestre, C; Eschalier, A; Laurido, C; Paeile, C; Alvarez, P; Soto-Moyano, R
      Antinociceptive effect of clomipramine in monoarthritic rats as revealed by the paw pressure test and the C-fiber-evoked reflex

      EUROPEAN JOURNAL OF PHARMACOLOGY
    57. du Toit, PL; van Kradenburg, J; Niehaus, D; Stein, DJ
      Comparison of obsessive-compulsive disorder patients with and without comorbid putative obsessive-compulsive spectrum disorders using a structured clinical interview

      COMPREHENSIVE PSYCHIATRY
    58. Foster, PS; Eisler, RM
      An integrative approach to the treatment of obsessive-compulsive disorder

      COMPREHENSIVE PSYCHIATRY
    59. Park, JM; Mataix-Cols, D; Marks, IM; Ngamthipwatthana, T; Marks, M; Araya, R; Al-Kubaisy, T
      Two-year follow-up after a randomised controlled trial of self- and clinician-accompanied exposure for phobia/panic disorders

      BRITISH JOURNAL OF PSYCHIATRY
    60. Ardid, D; Alloui, A; Brousse, G; Jourdan, D; Picard, P; Dubray, C; Eschalier, A
      Potentiation of the antinociceptive effect of clomipramine by a 5-ht(1A) antagonist in neuropathic pain in rats

      BRITISH JOURNAL OF PHARMACOLOGY
    61. Smith, DF; Geday, J
      PET neuroimaging of clomipramine challenge in humans: focus on the thalamus

      BRAIN RESEARCH
    62. Humble, M; Bejerot, S; Bergqvist, PBF; Bengtsson, F
      Reactivity of serotonin in whole blood: Relationship with drug response inobsessive-compulsive disorder

      BIOLOGICAL PSYCHIATRY
    63. Seksel, K; Lindeman, MJ
      Use of clomipramine in treatment of obsessive-compulsive disorder, separation anxiety and noise phobia in dogs: a preliminary, clinical study

      AUSTRALIAN VETERINARY JOURNAL
    64. Rowland, DL; Cooper, SE; Schneider, M
      Defining premature ejaculation for experimental and clinical investigations

      ARCHIVES OF SEXUAL BEHAVIOR
    65. Danielsson, B; Surugiu, I; Dzgoev, A; Mecklenburg, M; Ramanathan, K
      Optical detection of pesticides and drugs based on chemiluminescence-fluorescence assays

      ANALYTICA CHIMICA ACTA
    66. Flannigan, G; Dodman, NH
      Risk factors and behaviors associated with separation anxiety in dogs

      JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION
    67. Pryor, PA; Hart, BL; Cliff, KD; Bain, MJ
      Effects of a selective serotonin reuptake inhibitor on urine spraying behavior in cats

      JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION
    68. Tomkins, GE; Jackson, JL; O'Malley, PG; Balden, E; Santoro, JE
      Treatment of chronic headache with antidepressants: A meta-analysis

      AMERICAN JOURNAL OF MEDICINE
    69. Markianos, M; Hatzimanolis, J; Lykouras, L
      Neuroendocrine serotonergic and dopaminergic responsivity in male schizophrenic patients during treatment with neuroleptics and after switch to risperidone

      PSYCHOPHARMACOLOGY
    70. Vargas, LC; Schenberg, LC
      Long-term effects of clomipramine and fluoxetine on dorsal periaqueductal grey-evoked innate defensive behaviours of the rat

      PSYCHOPHARMACOLOGY
    71. Heikkinen, T; Ekblad, U; Laine, K
      Transplacental transfer of amitriptyline and nortriptyline in isolated perfused human placenta

      PSYCHOPHARMACOLOGY
    72. Baving, L; Schmidt, MH
      Obsessive-compulsive disorder, frontostriatal system and effect upon the serotonergic system

      ZEITSCHRIFT FUR KINDER-UND JUGENDPSYCHIATRIE UND PSYCHOTHERAPIE
    73. Wiersma, J; Honig, A; Peters, FPJ
      Clomipramine-induced allergic hepatitis: A case report

      INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
    74. Antelman, SM; Levine, J; Gershon, S
      Time-dependent sensitization: the odyssey of a scientific heresy from the laboratory to the door of the clinic

      MOLECULAR PSYCHIATRY
    75. Ueda, N; Yoshimura, R; Eto, S; Terao, T; Nakamura, J
      Delirious episodes induced by intravenous administration of clomipramine associated with an acute increase in its plasma concentrations

      PSYCHIATRY AND CLINICAL NEUROSCIENCES
    76. Kawahara, T; Ueda, Y; Mitsuyama, Y
      A case report of refractory obsessive-compulsive disorder improved by risperidone augmentation of clomipramine treatment

      PSYCHIATRY AND CLINICAL NEUROSCIENCES
    77. Levitan, RD; Shen, JH; Jindal, R; Driver, HS; Kennedy, SH; Shapiro, CM
      Preliminary randomized double-blind placebo-controlled trial of tryptophancombined with fluoxetine to treat major depressive disorder: antidepressant and hypnotic effects

      JOURNAL OF PSYCHIATRY & NEUROSCIENCE
    78. Alboni, P; Bondanelli, M; Dinelli, M; Gruppillo, P; Franceschetti, P; Marchi, P; degli Uberti, EC
      Role of the serotonergic system in the genesis of vasovagal syncope

      EUROPACE
    79. Hirschfeld, RMA
      Sertraline in the treatment of anxiety disorders

      DEPRESSION AND ANXIETY
    80. Koran, LM; Leventhal, JL; Fireman, B; Jacobson, A
      Pharmacotherapy of obsessive-compulsive disorder in a health maintenance organization

      AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
    81. Neziroglu, F; Yaryura-Tobias, JA; Walz, J; McKay, D
      The effect of fluvoxamine and behavior therapy on children and adolescentswith obsessive-compulsive disorder

      JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
    82. Eap, CB
      On the usefulness of therapeutic drug monitoring of methadone

      EUROPEAN ADDICTION RESEARCH
    83. Thomsen, PH
      Obsessive-compulsive disorder: pharmacological treatment

      EUROPEAN CHILD & ADOLESCENT PSYCHIATRY
    84. Yannielli, PC; Cadeiras, M; Gregoretti, L; Kargieman, L; Cardinali, DP; Golombek, DA
      Effects of clomipramine administration on syrian hamster circadian system and behavior

      BIOLOGICAL RHYTHM RESEARCH
    85. Weigmann, H; Hartter, S; Bagli, M; Hiemke, C
      Steady state concentrations of clomipramine and its major metabolite desmethylclomipramine in rat brain and serum after oral administration of clomipramine

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    86. Dannon, PN; Sasson, Y; Hirschmann, S; Iancu, I; Grunhaus, LJ; Zohar, J
      Pindolol augmentation in treatment-resistant obsessive compulsive disorder: a double-blind placebo controlled trial

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    87. Nutt, D
      Treatment of depression and concomitant anxiety

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    88. Bejerot, S; von Knorring, L; Ekselius, L
      Personality traits and smoking in patients with obsessive-compulsive disorder

      EUROPEAN PSYCHIATRY
    89. Kruger, S; Braunig, P; Hoffler, J; Shugar, G; Borner, I; Langkrar, J
      Prevalence of obsessive-compulsive disorder in schizophrenia and significance of motor symptoms

      JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES
    90. Hwang, MY; Morgan, JE; Losconzcy, MF
      Clinical and neuropsychological profiles of obsessive-compulsive schizophrenia: A pilot study

      JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES
    91. Matson, JL; Bamburg, JW; Mayville, EA; Pinkston, J; Bielecki, J; Kuhn, D; Smalls, Y; Logan, JR
      Psychopharmacology and mental retardation: a 10 year review (1990-1999)

      RESEARCH IN DEVELOPMENTAL DISABILITIES
    92. Delini-Stula, A
      Milnacipran: An antidepressant with dual selectivity of action on noradrenaline and serotonin uptake

      HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
    93. Ondarza, RN; Hernandez, E; Iturbe, A; Hurtado, G
      Inhibitory and lytic effects of phenothiazine derivatives and related tricyclic neuroleptic compounds, on Entamoeba histolytica HK9 and HMI trophozoites

      BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY
    94. Hollander, E; Kaplan, A; Cartwright, C; Reichman, D
      Venlafaxine in children, adolescents, and young adults with autism spectrum disorders: An open retrospective clinical report

      JOURNAL OF CHILD NEUROLOGY
    95. Chen, H; Gaul, F; Guo, D; Maycock, A
      Determination of loperamide in rat plasma and bovine serum albumin by LC

      JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
    96. Todorov, C; Freeston, MH; Borgeat, F
      On the pharmacotherapy of obsessive-compulsive disorder: Is a consensus possible?

      CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
    97. Al-Sughayir, MA
      In-patient treatment for resistant obsessive-compulsive disorder

      SAUDI MEDICAL JOURNAL
    98. Reznik, I; Sirota, P
      An open study of fluvoxamine augmentation of neuroleptics in schizophreniawith obsessive and compulsive symptoms

      CLINICAL NEUROPHARMACOLOGY
    99. Radomski, JW; Dursun, SM; Reveley, MA; Kutcher, SP
      An exploratory approach to the serotonin syndrome: an update of clinical phenomenology and revised diagnostic criteria

      MEDICAL HYPOTHESES
    100. Stein, DJ; Ludik, J
      A neural network of obsessive-compulsive disorder: cognitive disinhibitionand neurotransmitter dysfunction modelling

      MEDICAL HYPOTHESES


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 10/12/19 alle ore 01:47:03